SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
VaccinesInfectious Disease

PUBLISHER: Grand View Research | PRODUCT CODE: 2132247

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2132247

Malaria Therapeutics Market Size, Share & Trends Analysis Report By Drug Class, By Therapeutic Indication, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Malaria Therapeutics Market Summary

The global malaria therapeutics market size was valued at USD 3.1 billion in 2025 and is projected to grow from USD 3.2 billion in 2026 to USD 5.0 billion by 2033, at a CAGR of 6.5% from 2026 to 2033. The Middle East & Africa dominated the market, accounting for the largest revenue share of 47.1% in 2025. The malaria therapeutics industry growth is driven by the continued burden of malaria in endemic regions, particularly across sub-Saharan Africa and parts of the Asia Pacific, where sustained transmission creates consistent demand for effective treatment options.

The malaria therapeutics industry growth is driven by the continued burden of malaria in endemic regions, particularly across sub-Saharan Africa and parts of the Asia Pacific, where sustained transmission creates consistent demand for effective treatment options.

Growth in the market is supported by government-led malaria control programs, funding from international health organizations, and the increasing availability of artemisinin-based combination therapies (ACTs) through public health initiatives. Rising surveillance for drug-resistant Plasmodium falciparum strains has encouraged pharmaceutical companies and research organizations to advance the development of novel antimalarial therapies and combination regimens. In addition, improvements in diagnostic access and early case detection have strengthened timely treatment, contributing to better disease management. For instance, in July 2025, Novartis, in collaboration with Medicines for Malaria Venture (MMV), received Swissmedic approval for Coartem Baby (artemether-lumefantrine), the first malaria treatment specifically developed for newborns and young infants, addressing a long-standing treatment gap in malaria-endemic regions and supporting broader access to age-appropriate antimalarial therapies.

Global Malaria Therapeutics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global malaria therapeutics market report based on drug class, therapeutic indication, route of administration, distribution channel, and region:

  • Drug Class Outlook (Revenue, USD Billion, 2021 - 2033)
  • Artemisinin-based Combination Therapies (ACTs)
  • Non-Artemisinin Antimalarial Drugs
  • 8-Aminoquinolines
  • Therapeutic Indication Outlook (Revenue, USD Billion, 2021 - 2033)
  • Uncomplicated Malaria
  • Severe Malaria
  • Relapse Prevention (Radical Cure)
  • Malaria Chemoprophylaxis
  • Route of Administration Outlook (Revenue, USD Billion, 2021 - 2033)
  • Oral
  • Parenteral
  • Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Government & Institutional Procurement
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68040-940-2

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Therapeutic Indication
    • 1.2.3. Route of Administration
    • 1.2.4. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Malaria Therapeutics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Malaria Therapeutics Market: Drug Class Business Analysis

  • 4.1. Drug Class Market Share, 2025 & 2033
  • 4.2. Drug Class Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Billion)
  • 4.4. Artemisinin-based Combination Therapies (ACTs)
    • 4.4.1. Artemisinin-based Combination Therapies (ACTs) Market, 2021 - 2033 (USD Billion)
  • 4.5. Non-Artemisinin Antimalarial Drugs
    • 4.5.1. Non-Artemisinin Antimalarial Drugs Market, 2021 - 2033 (USD Billion)
  • 4.6. 8-Aminoquinolines
    • 4.6.1. 8-Aminoquinolines Market, 2021 - 2033 (USD Billion)

Chapter 5. Malaria Therapeutics Market: Therapeutic Indication Business Analysis

  • 5.1. Therapeutic Indication Market Share, 2025 & 2033
  • 5.2. Therapeutic Indication Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Therapeutic Indication, 2021 to 2033 (USD Billion)
  • 5.4. Uncomplicated Malaria
    • 5.4.1. Uncomplicated Malaria Market, 2021 - 2033 (USD Billion)
  • 5.5. Severe Malaria
    • 5.5.1. Severe Malaria Market, 2021 - 2033 (USD Billion)
  • 5.6. Relapse Prevention (Radical Cure)
    • 5.6.1. Relapse Prevention (Radical Cure) Market, 2021 - 2033 (USD Billion)
  • 5.7. Malaria Chemoprophylaxis
    • 5.7.1. Malaria Chemoprophylaxis Market, 2021 - 2033 (USD Billion)

Chapter 6. Malaria Therapeutics Market: Route of Administration Business Analysis

  • 6.1. Route of Administration Market Share, 2025 & 2033
  • 6.2. Route of Administration Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2021 to 2033 (USD Billion)
  • 6.4. Oral
    • 6.4.1. Oral Market, 2021 - 2033 (USD Billion)
  • 6.5. Parenteral
    • 6.5.1. Parenteral Market, 2021 - 2033 (USD Billion)

Chapter 7. Malaria Therapeutics Market: Distribution Channel Business Analysis

  • 7.1. Distribution Channel Market Share, 2025 & 2033
  • 7.2. Distribution Channel Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Billion)
  • 7.4. Hospital Pharmacies
    • 7.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Billion)
  • 7.5. Retail Pharmacies
    • 7.5.1. Retail Pharmacies Market, 2021 - 2033 (USD Billion)
  • 7.6. Online Pharmacies
    • 7.6.1. Online Pharmacies Market, 2021 - 2033 (USD Billion)
  • 7.7. Government & Institutional Procurement
    • 7.7.1. Government & Institutional Procurement Market, 2021 - 2033 (USD Billion)

Chapter 8. Malaria Therapeutics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2025 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 8.4. North America
    • 8.4.1. North America Malaria Therapeutics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Billion)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Framework
      • 8.4.2.5. U.S. Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Framework
      • 8.4.3.5. Canada Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Framework
      • 8.4.4.5. Mexico Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.5. Europe
    • 8.5.1. Europe Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Framework
      • 8.5.2.5. UK Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Framework
      • 8.5.3.5. Germany Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Reimbursement Framework
      • 8.5.4.5. France Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Target Disease Prevalence
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Reimbursement Framework
      • 8.5.5.5. Italy Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Target Disease Prevalence
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Reimbursement Framework
      • 8.5.6.5. Spain Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Target Disease Prevalence
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Reimbursement Framework
      • 8.5.7.5. Denmark Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Target Disease Prevalence
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Reimbursement Framework
      • 8.5.8.5. Sweden Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Target Disease Prevalence
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Reimbursement Framework
      • 8.5.9.5. Norway Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Framework
      • 8.6.2.5. Japan Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Framework
      • 8.6.3.5. China Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Framework
      • 8.6.4.5. India Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Framework
      • 8.6.5.5. Australia Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Target Disease Prevalence
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Reimbursement Framework
      • 8.6.6.5. South Korea Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Target Disease Prevalence
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Reimbursement Framework
      • 8.6.7.5. Thailand Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.7. Latin America
    • 8.7.1. Latin America Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Target Disease Prevalence
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Reimbursement Framework
      • 8.7.2.5. Brazil Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Target Disease Prevalence
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Reimbursement Framework
      • 8.7.3.5. Argentina Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.8. Middle East and Africa
    • 8.8.1. Middle East and Africa Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Target Disease Prevalence
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Reimbursement Framework
      • 8.8.2.5. South Africa Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Target Disease Prevalence
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Reimbursement Framework
      • 8.8.3.5. Saudi Arabia Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Target Disease Prevalence
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. Reimbursement Framework
      • 8.8.4.5. UAE Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Target Disease Prevalence
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Reimbursement Framework
      • 8.8.5.5. Kuwait Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Novartis AG
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. GSK plc
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Sanofi
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. Cipla Limited
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Ipca Laboratories Limited
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Sun Pharmaceutical Industries Limited
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Ajanta Pharma Limited
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Strides Pharma Science Limited
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Shin Poong Pharmaceutical Co., Ltd.
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. KPC Pharmaceuticals, Inc.
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives
Show more
Product Code: GVR-4-68040-940-2

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Malaria Therapeutics Market, by region, 2021 - 2033 (USD Billion)
  • Table 4 Global Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 5 Global Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 6 Global Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 7 Global Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 8 North America Malaria Therapeutics Market, by country, 2021 - 2033 (USD Billion)
  • Table 9 North America Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 10 North America Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 11 North America Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 12 North America Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 13 U.S. Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 14 U.S. Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 15 U.S. Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 16 U.S. Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 17 Canada Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 18 Canada Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 19 Canada Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 20 Canada Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 21 Mexico Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 22 Mexico Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 23 Mexico Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 24 Mexico Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 25 Europe Malaria Therapeutics Market, by country, 2021 - 2033 (USD Billion)
  • Table 26 Europe Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 27 Europe Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 28 Europe Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 29 Europe Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 30 UK Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 31 UK Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 32 UK Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 33 UK Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 34 Germany Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 35 Germany Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 36 Germany Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 37 Germany Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 38 France Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 39 France Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 40 France Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 41 France Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 42 Italy Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 43 Italy Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 44 Italy Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 45 Italy Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 46 Spain Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 47 Spain Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 48 Spain Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 49 Spain Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 50 Norway Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 51 Norway Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 52 Norway Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 53 Norway Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 54 Denmark Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 55 Denmark Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 56 Denmark Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 57 Denmark Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 58 Sweden Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 59 Sweden Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 60 Sweden Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 61 Sweden Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 62 Asia Pacific Malaria Therapeutics Market, by country, 2021 - 2033 (USD Billion)
  • Table 63 Asia Pacific Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 64 Asia Pacific Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 65 Asia Pacific Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 66 Asia Pacific Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 67 Japan Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 68 Japan Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 69 Japan Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 70 Japan Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 71 China Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 72 China Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 73 China Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 74 China Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 75 India Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 76 India Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 77 India Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 78 India Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 79 Australia Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 80 Australia Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 81 Australia Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 82 Australia Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 83 South Korea Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 84 South Korea Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 85 South Korea Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 86 South Korea Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 87 Thailand Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 88 Thailand Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 89 Thailand Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 90 Thailand Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 91 Latin America Malaria Therapeutics Market, by country, 2021 - 2033 (USD Billion)
  • Table 92 Latin America Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 93 Latin America Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 94 Latin America Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 95 Latin America Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 96 Brazil Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 97 Brazil Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 98 Brazil Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 99 Brazil Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 100 Argentina Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 101 Argentina Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 102 Argentina Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 103 Argentina Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 104 Middle East & Africa Malaria Therapeutics Market, by country, 2021 - 2033 (USD Billion)
  • Table 105 Middle East & Africa Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 106 Middle East & Africa Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 107 Middle East & Africa Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 108 Middle East & Africa Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 109 South Africa Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 110 South Africa Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 111 South Africa Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 112 South Africa Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 113 Saudi Arabia Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 114 Saudi Arabia Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 115 Saudi Arabia Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 116 Saudi Arabia Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 117 UAE Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 118 UAE Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 119 UAE Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 120 UAE Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)
  • Table 121 Kuwait Malaria Therapeutics Market, by drug class, 2021 - 2033 (USD Billion)
  • Table 122 Kuwait Malaria Therapeutics Market, by therapeutic Indication, 2021 - 2033 (USD Billion)
  • Table 123 Kuwait Malaria Therapeutics Market, by route of administration, 2021 - 2033 (USD Billion)
  • Table 124 Kuwait Malaria Therapeutics Market, by distribution channel, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Malaria therapeutics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape
  • Fig. 10 Malaria therapeutics market dynamics
  • Fig. 11 Malaria therapeutics market: Porter's five forces analysis
  • Fig. 12 Malaria therapeutics market: PESTLE analysis
  • Fig. 13 Drug Class market, 2021 - 2033 (USD Billion)
  • Fig. 14 Artemisinin-based combination therapies (ACTs) market, 2021 - 2033 (USD Billion)
  • Fig. 15 Non-artemisinin antimalarial drugs market, 2021 - 2033 (USD Billion)
  • Fig. 16 8-Aminoquinolines market, 2021 - 2033 (USD Billion)
  • Fig. 17 Therapeutic Indication market, 2021 - 2033 (USD Billion)
  • Fig. 18 Uncomplicated malaria market, 2021 - 2033 (USD Billion)
  • Fig. 19 Severe malaria market, 2021 - 2033 (USD Billion)
  • Fig. 20 Relapse prevention (radical cure) market, 2021 - 2033 (USD Billion)
  • Fig. 21 Malaria chemoprophylaxis market, 2021 - 2033 (USD Billion)
  • Fig. 22 Route of Administration market, 2021 - 2033 (USD Billion)
  • Fig. 23 Oral market, 2021 - 2033 (USD Billion)
  • Fig. 24 Parenteral market, 2021 - 2033 (USD Billion)
  • Fig. 25 Distribution channel market, 2021 - 2033 (USD Billion)
  • Fig. 26 Hospital pharmacies market, 2021 - 2033 (USD Billion)
  • Fig. 27 Retail pharmacies market, 2021 - 2033 (USD Billion)
  • Fig. 28 Online pharmacies market, 2021 - 2033 (USD Billion)
  • Fig. 29 Government & institutional procurement market, 2021 - 2033 (USD Billion)
  • Fig. 30 Malaria therapeutics market revenue, by region
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 North America malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 33 U.S. country dynamics
  • Fig. 34 U.S. malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 35 Canada country dynamics
  • Fig. 36 Canada malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 37 Mexico country dynamics
  • Fig. 38 Mexico malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 39 Europe malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 40 UK country dynamics
  • Fig. 41 UK malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 42 Germany country dynamics
  • Fig. 43 Germany malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 44 France country dynamics
  • Fig. 45 France malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 46 Italy country dynamics
  • Fig. 47 Italy malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 48 Spain country dynamics
  • Fig. 49 Spain malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 50 Norway country dynamics
  • Fig. 51 Norway malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 52 Sweden country dynamics
  • Fig. 53 Sweden malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 54 Denmark country dynamics
  • Fig. 55 Denmark malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 56 Asia Pacific malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 57 Japan country dynamics
  • Fig. 58 Japan malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 59 China country dynamics
  • Fig. 60 China malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 61 India country dynamics
  • Fig. 62 India malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 63 Australia country dynamics
  • Fig. 64 Australia malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 65 South Korea country dynamics
  • Fig. 66 South Korea malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 67 Thailand country dynamics
  • Fig. 68 Thailand malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 69 Latin America malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 70 Brazil country dynamics
  • Fig. 71 Brazil malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 72 Argentina country dynamics
  • Fig. 73 Argentina malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 74 MEA malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 75 South Africa country dynamics
  • Fig. 76 South Africa malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 77 Saudi Arabia country dynamics
  • Fig. 78 Saudi Arabia malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 79 UAE country dynamics
  • Fig. 80 UAE malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 81 Kuwait country dynamics
  • Fig. 82 Kuwait malaria therapeutics market, 2021 - 2033 (USD Billion)
  • Fig. 83 Company categorization
  • Fig. 84 Company market position analysis
  • Fig. 85 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!